Table 2.
4-year outcomes during the follow-up period
| Overall N = 572 |
Reduced BMI N = 191 |
Maintained BMI N = 191 |
Elevated BMI N = 190 |
p value | |
|---|---|---|---|---|---|
| MACEs, n (%) | 60 (10.5%) | 31 (16.2%) | 13 (6.8%) | 16 (8.4%) | < 0.01 |
| All-cause death, n (%) | 43 (7.5%) | 23 (12.0%) | 9 (4.7%) | 11 (5.8%) | 0.01 |
| Q-wave myocardial infarction, n (%) | 4 (0.7%) | 4 (2.1%) | 0 (0.0%) | 0 (0.0%) | 0.02 |
| Stroke, n (%) | 17 (3.0%) | 6 (3.1%) | 5 (2.6%) | 6 (3.2%) | 0.94 |
| Cardiac death, n (%) | 38 (6.6%) | 20 (10.5%) | 8 (4.2%) | 10 (5.3%) | 0.03 |
| Bleeding event, n (%) | 23 (4.0%) | 12 (6.3%) | 6 (3.1%) | 5 (2.6%) | 0.15 |
| Target lesion revascularization, n (%) | 31 (5.4%) | 13 (6.8%) | 12 (6.3%) | 6 (3.2%) | 0.24 |
BMI body mass index, MACE major adverse cardiac or cerebrovascular events